SGP

NASDAQ Healthcare

SpyGlass Pharma, Inc. - Common Stock

Biotechnology

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was incorporated in 2019 and is based in Aliso Viejo, California.

�� 市场数据
价格$20.76
成交量157,655
市值694.08M
RSI（14日）56.8
50日均线$20.56
52周最高$32.44
52周最低$17.06
Forward P/E-7.70
Price / Book2.78
在Yahoo Finance查看 →
🎯 投资策略评分

SGP 在各投资策略中的评分。分数越高，越符合该策略目标。

💰 Dividend Daddy 30/100
高股息率 + 低波动性
🚀 Moon Shot 7/100
高增长潜力（高贝塔 + 超卖）
🔪 Falling Knife 57/100
逆向投资（超卖 + 低于移动均线）
🎈 Over-Hyped 52/100
超买股票（潜在做空标的）
🐋 Institutional Whale 17/100
大盘、机构级别股票
🔍 策略解读

最佳匹配： 🔪 Falling Knife (57/100) — 此策略 逆向投资（超卖 + 低于移动均线）.

评分最低的策略： 🚀 Moon Shot (7/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →

📚 了解更多
本页指标
教育文章
网站资源
在文本中查找 SGP in your text

粘贴任何文章、记录或帖子 — 工具将提取 SGP 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-07-16.